ATE366580T1 - Hemmer der natrium-ion absorption und beschleuniger der natrium-ion exkretion als wirkstoffe zur vorbeugung oder behandlung von erkrankungen die sich ergeben aus übermässiges einnehmen von kochsalz - Google Patents

Hemmer der natrium-ion absorption und beschleuniger der natrium-ion exkretion als wirkstoffe zur vorbeugung oder behandlung von erkrankungen die sich ergeben aus übermässiges einnehmen von kochsalz

Info

Publication number
ATE366580T1
ATE366580T1 AT98961530T AT98961530T ATE366580T1 AT E366580 T1 ATE366580 T1 AT E366580T1 AT 98961530 T AT98961530 T AT 98961530T AT 98961530 T AT98961530 T AT 98961530T AT E366580 T1 ATE366580 T1 AT E366580T1
Authority
AT
Austria
Prior art keywords
sodium ion
salt
preventing
inhibiters
accelerators
Prior art date
Application number
AT98961530T
Other languages
English (en)
Inventor
Takaya Sato
Tutomu Uehara
Ippei Yamaoka
Kozo Asagi
Masaru Kobayashi
Hideaki Kohri
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of ATE366580T1 publication Critical patent/ATE366580T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0036—Galactans; Derivatives thereof
    • C08B37/0042—Carragenan or carragen, i.e. D-galactose and 3,6-anhydro-D-galactose, both partially sulfated, e.g. from red algae Chondrus crispus or Gigantia stellata; kappa-Carragenan; iota-Carragenan; lambda-Carragenan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT98961530T 1997-12-25 1998-12-24 Hemmer der natrium-ion absorption und beschleuniger der natrium-ion exkretion als wirkstoffe zur vorbeugung oder behandlung von erkrankungen die sich ergeben aus übermässiges einnehmen von kochsalz ATE366580T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP35760997 1997-12-25

Publications (1)

Publication Number Publication Date
ATE366580T1 true ATE366580T1 (de) 2007-08-15

Family

ID=18455004

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98961530T ATE366580T1 (de) 1997-12-25 1998-12-24 Hemmer der natrium-ion absorption und beschleuniger der natrium-ion exkretion als wirkstoffe zur vorbeugung oder behandlung von erkrankungen die sich ergeben aus übermässiges einnehmen von kochsalz

Country Status (7)

Country Link
US (1) US6369043B1 (de)
EP (1) EP1043022B1 (de)
AT (1) ATE366580T1 (de)
CA (1) CA2316387A1 (de)
DE (1) DE69838076T2 (de)
NO (1) NO20003283L (de)
WO (1) WO1999033478A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027789A1 (en) * 2000-01-14 2003-02-06 Ippei Yamaoka Inhibitors against sodium ion absorption, and preventive or therapeutic agents and foods containing the same
CN101528194B (zh) * 2006-09-26 2013-06-12 巴斯夫美容护理公司 用于化妆品中的海洋提取物和生物发酵物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4353890A (en) * 1979-10-24 1982-10-12 Colgate-Palmolive Company Stabilization of carrageenan-containing toothpaste
JP3194267B2 (ja) * 1990-01-09 2001-07-30 株式会社アドバンス 排塩促進組成物の製造方法
US5344844A (en) * 1990-01-09 1994-09-06 Kabushiki Kaisya Advance Salt excretion promoting composition
JP3206045B2 (ja) 1991-10-11 2001-09-04 スズキ株式会社 自動変速機の操作装置
JPH0648950A (ja) * 1992-07-30 1994-02-22 Taito Kk 抗潰瘍剤

Also Published As

Publication number Publication date
WO1999033478A1 (fr) 1999-07-08
NO20003283D0 (no) 2000-06-22
NO20003283L (no) 2000-08-25
DE69838076D1 (de) 2007-08-23
EP1043022A1 (de) 2000-10-11
EP1043022B1 (de) 2007-07-11
US6369043B1 (en) 2002-04-09
DE69838076T2 (de) 2008-03-20
CA2316387A1 (en) 1999-07-08
EP1043022A4 (de) 2003-07-30

Similar Documents

Publication Publication Date Title
DE60214376D1 (de) Zusammensetzung zur behandlung von huf- und klauenerkrankungen
BR9812437A (pt) Composições germicidas para tratamento dedoenças infecciosas dos cascos em animais,compreendendo sal de cobre, um composto amÈnioquaternário e peróxido
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
ATE123943T1 (de) Mittel zur behandlung und vorbeugung von bauchentzündungen, die als wirkstoff zink-l- carnosin-salze oder -komplexe enthalten.
ATE207355T1 (de) Behandlung von hyperproliferativen gefässerkrankungen
WO2002053101A3 (en) Method for treating fibrotic diseases or other indications
BRPI0411677A (pt) métodos de uso de compostos heterocìclicos [3.2.0] e seus análogos
MXPA05003302A (es) Compuestos de piperazina terapeuticos.
ATE412646T1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
ATE496048T1 (de) Phenylcarboxamidverbindungen zur schmerzbehandlung
FR2819723B1 (fr) Composition halogene, son procede de preparation et ses utilisations
MXPA05000765A (es) Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos.
TR200101649T2 (tr) Piperazin türevleri.
BR9808221A (pt) Método de tratamento de tumor.
WO2004110151A8 (en) Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
EE200100478A (et) Vahend artriitilise haiguse raviks
EP1178796A4 (de) Aminoimidazolcarboxamidesalze zur vorbeugung und behandlung von leberkrankheiten
ATE270891T1 (de) Triazinoneverbindungen für die behhandlung von krankheiten verursacht durch neospora und toxoplasma
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
DE602004024221D1 (de) Behandlung von entzündlichen darmerkrankungen mit 2-methylen-19-nor-vitamin d verbindungen
NO982989L (no) Anvendelse av inhibitorer av den cellulµre Na+/H+-utbytteren (NHE) for fremstilling av et medikament for respiratorstimulering
DE69838076D1 (de) Hemmer der natrium-ion absorption und beschleuniger der natrium-ion exkretion als wirkstoffe zur vorbeugung oder behandlung von erkrankungen die sich ergeben aus übermässiges einnehmen von kochsalz
ATE374037T1 (de) Pimenta-extrakt enthaltende zusammensetzung in behandlungsverfahren für wassertiere
ATE302011T1 (de) PONAZURIL ZUR BEHANDLUNG VON DURCH COCCIDIA NEUROLOGISCHEN UND ßABORTIGENICß VERURSACHTEN ERKRANKUNGEN
ATE317263T1 (de) Diphosphonat derivate von therapeutisch wirksamen stoffen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties